Source link : https://www.newshealth.biz/health-news/reteplase-superior-to-alteplase-in-chinese-stroke-trial/
A new trial has found the thrombolytic reteplase to be superior to alteplase in patients with acute ischemic stroke presenting within 4.5 hours of symptom onset, with an excellent functional outcome at 90 days. The Chinese RAISE trial also showed a higher rate of intracranial hemorrhage with reteplase than with alteplase, although the incidence of […]
Author : News Health
Publish date : 2024-07-01 06:50:28
Copyright for syndicated content belongs to the linked Source.
Categories